Published in J Immunol Res on May 18, 2016
HMGB1 release by H2O2-induced hepatocytes is regulated through calcium overload and 58-F interference. Cell Death Discov (2017) 0.75
Peptide hormones and lipopeptides: from self-assembly to therapeutic applications. J Pept Sci (2017) 0.75
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest (2004) 3.89
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest (2012) 2.98
RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol (2005) 2.96
A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem (1973) 2.92
Structure of the HMG box motif in the B-domain of HMG1. EMBO J (1993) 2.84
Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med (2012) 2.79
Mechanisms of disease: neuropathic pain--a clinical perspective. Nat Clin Pract Neurol (2006) 2.44
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol (2006) 2.44
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med (2012) 2.35
Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci (2001) 2.15
A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem (2007) 2.05
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis (2007) 2.01
HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. Am J Physiol Cell Physiol (2010) 1.75
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism. Immunity (2014) 1.63
Emerging role of Toll-like receptors in the control of pain and itch. Neurosci Bull (2012) 1.60
Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain (2008) 1.59
Toll-like receptor signaling pathways. Front Immunol (2014) 1.58
IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun (2011) 1.57
Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis (2009) 1.51
RAGE: a single receptor fits multiple ligands. Trends Biochem Sci (2011) 1.39
The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain. Neuroscience (2008) 1.37
Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab (2013) 1.30
Toll-like receptors in chronic pain. Exp Neurol (2011) 1.29
HMGB1: a signal of necrosis. Autoimmunity (2007) 1.28
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol Ther (2013) 1.27
Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol (2011) 1.24
The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain (2011) 1.23
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol (2009) 1.21
TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res (2012) 1.18
The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med (2014) 1.17
Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain (2010) 1.17
Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis. Pain (2014) 1.08
HMGB1: roles in base excision repair and related function. Biochim Biophys Acta (2010) 1.07
Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. J Hepatol (2015) 1.05
High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med (2012) 1.02
HMGB1 increases permeability of the endothelial cell monolayer via RAGE and Src family tyrosine kinase pathways. Inflammation (2012) 1.02
The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway. Mol Cell Biochem (2013) 1.01
Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol (2011) 1.01
Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal (2014) 1.00
HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B. Autophagy (2013) 0.98
Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem (2012) 0.96
Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscle. Ann N Y Acad Sci (2010) 0.95
NMDA receptor antagonists for the treatment of neuropathic pain. Pain Med (2010) 0.95
Neuropathic pain: is quantitative sensory testing helpful? Curr Diab Rep (2012) 0.94
Pharmacological options for the management of refractory cancer pain-what is the evidence? Support Care Cancer (2015) 0.93
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study. Clinicoecon Outcomes Res (2014) 0.92
Emotional consequences of neuropathic pain: insight from preclinical studies. Neurosci Biobehav Rev (2014) 0.92
The alarmin functions of high-mobility group proteins. Biochim Biophys Acta (2010) 0.91
Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord. Pain Physician (2015) 0.90
Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis (2013) 0.90
Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain. Brain Behav Immun (2014) 0.89
High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes. Brain Res Bull (2012) 0.89
An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor. J Biol Chem (2014) 0.88
Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med (2015) 0.88
Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction. Neuropharmacology (2014) 0.86
Anti-HMGB1 neutralization antibody improves pain-related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats. Spine (Phila Pa 1976) (2011) 0.86
Is RAGE still a therapeutic target for Alzheimer's disease? Future Med Chem (2012) 0.86
Inflammation, DAMPs, tumor development, and progression: a vicious circle orchestrated by redox signaling. Antioxid Redox Signal (2013) 0.85
Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein. PLoS One (2012) 0.85
Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis. Neuropharmacology (2013) 0.84
Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1. PLoS One (2013) 0.84
HMGB1 as a potential therapeutic target for neuropathic pain. J Pharmacol Sci (2013) 0.83
Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations. Dis Mon (2014) 0.83
RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neurosci Biobehav Rev (2015) 0.83
Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J Neurochem (2015) 0.82
EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model. PLoS One (2014) 0.82
Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study. Patient (2015) 0.81
Reversal of complex regional pain syndrome type 2 and the subsequent management of complex regional pain syndrome type 1 occurring after corrective surgery for residual ulnar claw. Pain Med (2014) 0.81
Association of pain and CNS structural changes after spinal cord injury. Sci Rep (2016) 0.81
Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis. Front Cell Neurosci (2015) 0.80
LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia. Purinergic Signal (2015) 0.80
Promising treatments for neuropathic pain. Arq Neuropsiquiatr (2014) 0.80
Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain. Evid Based Complement Alternat Med (2014) 0.80
Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloproteinase-9 upregulation in mice with painful peripheral neuropathy. J Neurochem (2015) 0.79
Emerging drugs for neuropathic pain. Expert Opin Emerg Drugs (2014) 0.79
Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats. Br J Pharmacol (2013) 0.78
Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J Biol Chem (2015) 0.78
Regulation of Posttranslational Modifications of HMGB1 During Immune Responses. Antioxid Redox Signal (2016) 0.77
HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death? Atherosclerosis (2011) 0.77
Treatment for neuropathic pain and chronic inflammation using LASER in animal models. Conf Proc IEEE Eng Med Biol Soc (2015) 0.76
High-mobility group box 1 induces neuron autophagy in a rat spinal root avulsion model. Neuroscience (2015) 0.76
Diagnosis and management of neuropathic pain: review of literature and recommendations of the Polish Association for the study of pain and the Polish Neurological Society - part one. Neurol Neurochir Pol (2014) 0.76
JAB1 is Involved in Neuropathic Pain by Regulating JNK and NF-κB Activation After Chronic Constriction Injury. Neurochem Res (2015) 0.76
Connexin 43 Mediates CXCL12 Production from Spinal Dorsal Horn to Maintain Bone Cancer Pain in Rats. Neurochem Res (2015) 0.76
Neurological complications of breast cancer: study protocol of a prospective cohort study. BMJ Open (2014) 0.76
Overexpression of microRNA-141 relieves chronic constriction injury-induced neuropathic pain via targeting high-mobility group box 1. Int J Mol Med (2015) 0.76
The effect of transdermal nitroglycerin on pain control in diabetic patients with peripheral neuropathy. J Diabetes Metab Disord (2015) 0.76
Changes in the expression of the Toll-like receptor system in the aging rat kidneys. PLoS One (2014) 0.76
Melatonin relieves neuropathic allodynia through spinal MT2-enhanced PP2Ac and downstream HDAC4 shuttling-dependent epigenetic modification of hmgb1 transcription. J Pineal Res (2016) 0.75
High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retina. Exp Eye Res (2015) 0.75
The role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target? Biomed Res Int (2014) 0.80
Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases. Stem Cells Int (2015) 0.80
An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment. J Immunol Res (2016) 0.79
Role of Exosomal Noncoding RNAs in Lung Carcinogenesis. Biomed Res Int (2015) 0.77
Oleanolic Acid Induces Differentiation of Neural Stem Cells to Neurons: An Involvement of Transcription Factor Nkx-2.5. Stem Cells Int (2015) 0.75